The Diagnostics & Lab Testing Business Brief
By Damon Frank
Categories: Business, Health & Fitness, Medicine
The Diagnostics & Lab Testing Business Brief delivers a daily briefing on the business, technology, innovation, and market forces shaping the global diagnostics industry. From diagnostic devices, medical technology, AI-powered diagnostics, laboratory testing, and continuous glucose monitors (CGMs) to emerging testing technologies, point-of-care diagnostics, molecular diagnostics, and at-home testing, we cover the innovations transforming how diseases are detected, monitored, and diagnosed. Stay informed on earnings, mergers and acquisitions, venture funding, FDA approvals and clearances, regulatory developments, product launches, clinical breakthroughs, and competitive shifts across the diagnostics marketplace. Follow industry leaders including Labcorp, Quest Diagnostics, Abbott, Roche, Siemens Healthineers, Danaher, and Thermo Fisher Scientific, alongside the startups and innovators reshaping the future of diagnostics. Created for diagnostics executives, medical technology leaders, laboratory operators, founders, investors, entrepreneurs, and industry professionals who need to understand what's happening, why it matters, and where the industry is heading. Presented by Damon Frank, marketing strategist, media entrepreneur, and founder of Talent Branded. Produced using AI-assisted research and narration.
16 episodes indexed on PodSearch.
Recent episodes
- The Diagnostics & Lab Testing Business Brief — Saturday, November 7, 2026
The Diagnostics & Lab Testing Business Brief — Saturday, November 7, 2026 Natera appoints Solomon Moshkevich as CEO, effective immediately; Steve Chapman remains a consultant and board advisor. (Business Wire) OPKO Health Q3 2026: BioReference presented as discontinued operations ahead of its sale…
- The Diagnostics & Lab Testing Business Brief — Friday, November 6, 2026
The Diagnostics & Lab Testing Business Brief — Friday, November 6, 2026 Natera Q3 2026: revenue up 34.1% to $794.0M on about 1,093,100 tests processed; full-year revenue guidance raised to $3.005–$3.035B — Business Wire Guardant Health Q3 2026: revenue up 36% to $361.0M; Shield screening revenue…
- The Diagnostics & Lab Testing Business Brief — Thursday, November 5, 2026
The Diagnostics & Lab Testing Business Brief — Thursday, November 5, 2026 Siemens Healthineers begins carving out its in vitro diagnostics business as standalone Olyrian Diagnostics, with completion expected by mid-2028 — GlobeNewswire via TradingView; unit scale and margins — Reuters via…
- The Diagnostics & Lab Testing Business Brief — Wednesday, November 4, 2026
The Diagnostics & Lab Testing Business Brief — Wednesday, November 4, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Sapphiros and binx health combine to form Onvaro: the combination unites binx health's FDA-cleared, CLIA-waived binx io molecular…
- The Diagnostics & Lab Testing Business Brief — Tuesday, November 3, 2026
The Diagnostics & Lab Testing Business Brief — Tuesday, November 3, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Natera Signatera MRD test gains Medicare coverage in hepatocellular carcinoma: Medicare coverage through the CMS MolDX program includes…
- The Diagnostics & Lab Testing Business Brief — Monday, November 2, 2026
The Diagnostics & Lab Testing Business Brief — Monday, November 2, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Tempus AI reports third-quarter 2026 results: total revenue $411.5 million (+23%), Diagnostics revenue $303.5 million (+20%) on oncology…
- The Diagnostics & Lab Testing Business Brief — Sunday, November 1, 2026
The Diagnostics & Lab Testing Business Brief — Sunday, November 1, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Gliolab, the Glioblastoma Foundation's CLIA-certified genomic testing laboratory, begins accepting patient samples: announced Oct 31, 2026 —…
- The Diagnostics & Lab Testing Business Brief — Saturday, October 31, 2026
The Diagnostics & Lab Testing Business Brief — Saturday, October 31, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Labcorp and Quest press Congress on the RESULTS Act as PAMA payment cuts loom: reported Oct 30, 2026 — both CEOs used their third-quarter…
- The Diagnostics & Lab Testing Business Brief — Friday, October 30, 2026
The Diagnostics & Lab Testing Business Brief — Friday, October 30, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. DEVICE — Dexcom Q3 2026 results: reported Oct 29, 2026 — worldwide revenue $1.344 billion (+11% year over year; U.S. +14%, international…
- Element Biosciences Launches AVITI Dx in Ten EU Countries, Scipher PrismTcell, Deep Breathe FDA Clearance — Oct 29, 2026
The Diagnostics & Lab Testing Business Brief — Thursday, October 29, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Element Biosciences launches AVITI Dx™ in ten EU countries: announced Oct 29, 2026 — the company's first CE-marked in vitro diagnostic…
- Labcorp Raises Full-Year Guidance, Roche VENTANA BAP1 Mesothelioma Test, SEKISUI OSOM Combo Clearance — Oct 28, 2026
The Diagnostics & Lab Testing Business Brief — Wednesday, October 28, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Labcorp Q3 2026 results; guidance raised: announced Oct 28, 2026 — revenue $3.81 billion (+6.9%), diluted EPS $3.22 (+3.3%), adjusted EPS…
- Roche cobas smart e CE Mark, Abbott Launches Next-Gen Oncodetect MRD, Nautilus Joins ARPA-H SEEDS — Oct 27, 2026
The Diagnostics & Lab Testing Business Brief — Tuesday, October 27, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Roche receives CE Mark for cobas smart e immunoanalyser: announced Oct 27, 2026 — a compact, standalone benchtop platform (under 1 m², ~0.9…
- Senseonics Freedom One-Year CGM First-in-Human Study, Roche Diagnostics Sales, Delfi-Pro at ESMO — Oct 26, 2026
The Diagnostics & Lab Testing Business Brief — Monday, October 26, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. DEVICE — Senseonics begins first-in-human study of Freedom CGM: announced Oct 26, 2026 — an investigational, transmitter-free one-year CGM…
- Labcorp to Acquire Millennium Health, Veracyte Decipher Prostate, Natera Signatera ctDNA — Oct 25, 2026
The Diagnostics & Lab Testing Business Brief — Sunday, October 25, 2026 (v2, expanded device scope) The business behind the tests. Today's developments shaping the diagnostics industry. Labcorp to acquire Millennium Health: definitive agreement announced Oct 23, 2026 to acquire the specialty…
- Quest Diagnostics Quanum Breach, Tempus AI Expands BMS and Pathos AI Deals, Abbott Oncodetect Data — Oct 24, 2026
The Diagnostics & Lab Testing Business Brief — Saturday, October 24, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Quest Diagnostics Quanum breach: Quest disclosed in an SEC Form 8-K (Oct 22) that it learned Oct 21 of unauthorized access to its Quanum…
- Quest Diagnostics Q3 Results, EQT to Take Qiagen Private, Abbott Nutrition Spinoff — Oct 22, 2026
The Diagnostics & Lab Testing Business Brief — Thursday, October 22, 2026 The business behind the tests. Today's developments shaping the diagnostics industry. Quest Diagnostics Q3 2026 results: revenue of $3.10 billion, up 10.0%, adjusted EPS of $3.00, and full-year revenue and EPS guidance…
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.